FAZE MEDICINES
Live / Registered — Registered (as of 30 Nov 2021)
What this means for you
Registered since 30 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90206650
- Registration number
- 6577849
- Mark type
- Word mark
- Filed
- 24 Sept 2020
- Published for opposition
- 23 Mar 2021
- Registered
- 30 Nov 2021
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: research and development of therapeutics for the treatment of neurodegeneration diseases, cancers and viral diseases
Owner
- Faze Medicines, Inc., Cambridge, MA, US
- Faze Medicines, Inc., Cambridge, MA, US
- Faze Medicines, Inc., Cambridge, MA, US
Prosecution history
- 30 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 28 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Oct 2021 — USE AMENDMENT FILED
- 26 Oct 2021 — SOU EXTENSION 1 GRANTED
- 08 Oct 2021 — SOU EXTENSION 1 FILED
- 18 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 18 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION
- 03 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED